var data={"title":"Epidemiology, clinical manifestations, and diagnosis of melioidosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Epidemiology, clinical manifestations, and diagnosis of melioidosis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/contributors\" class=\"contributor contributor_credentials\">Bart Currie, MBBS, FRACP</a></dd><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/contributors\" class=\"contributor contributor_credentials\">Nicholas M Anstey, MBBS, FRACP, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/contributors\" class=\"contributor contributor_credentials\">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/contributors\" class=\"contributor contributor_credentials\">Allyson Bloom, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 12, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Melioidosis is an infection caused by the facultative intracellular gram-negative bacterium, <em>Burkholderia pseudomallei</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/1-3\" class=\"abstract_t\">1-3</a>]. This organism is a widely distributed environmental saprophyte in soil and fresh surface water in endemic regions [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/4\" class=\"abstract_t\">4</a>].</p><p>The epidemiology, pathogenesis, clinical manifestations, and diagnosis of melioidosis will be presented here. The treatment and prognosis of this disease are discussed separately. (See <a href=\"topic.htm?path=treatment-and-prognosis-of-melioidosis\" class=\"medical medical_review\">&quot;Treatment and prognosis of melioidosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span></p><p class=\"headingAnchor\" id=\"H100078067\"><span class=\"h2\">Geographic distribution</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Melioidosis occurs predominantly in Southeast Asia, northern Australia, South Asia (including India), and China (<a href=\"image.htm?imageKey=ID%2F73325\" class=\"graphic graphic_figure graphicRef73325 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/2,5-8\" class=\"abstract_t\">2,5-8</a>]. The majority of diagnosed cases are from Thailand [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/9-12\" class=\"abstract_t\">9-12</a>], Malaysia [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/13-16\" class=\"abstract_t\">13-16</a>], Singapore [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/17-23\" class=\"abstract_t\">17-23</a>], and northern Australia [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/24-26\" class=\"abstract_t\">24-26</a>]. Cases are also reported from Papua New Guinea [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/27\" class=\"abstract_t\">27</a>] and New Caledonia [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/28\" class=\"abstract_t\">28</a>]. Northeastern Thailand and parts of northern Australia are &quot;hyperendemic&quot; for melioidosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/10,24\" class=\"abstract_t\">10,24</a>], with seasonal peaks in the wet seasons. In 2010, there was been an increase in incidence in both northeast Thailand and northern Australia as well as in south Asia [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/29-31\" class=\"abstract_t\">29-31</a>]. </p><p>Melioidosis has been described outside the classic endemic regions. Most of such cases are acquired by visitors to endemic areas, with symptoms arising later following departure from the endemic area [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/32,33\" class=\"abstract_t\">32,33</a>]. However, sporadic human or animal cases and occasional environmental isolates of <em>B. pseudomallei</em> have been described from Africa, Indian Ocean countries (such as Mauritius), the Middle East, the Caribbean, and Central and South America [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/34-36\" class=\"abstract_t\">34-36</a>]. Some of these reports represent incorrect species diagnosis, but others have been confirmed as <em>B. pseudomallei</em>, making the endemic boundaries of melioidosis less clear [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/7,8,37\" class=\"abstract_t\">7,8,37</a>]. As an example, six cases of melioidosis were reported from eastern Puerto Rico between 1982 and 2012 [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/38\" class=\"abstract_t\">38</a>]. During investigation of two of those cases, seropositivity to <em>B. pseudomallei</em> was identified in a subset of individuals who lived in proximity to the index patients, and <em>B. pseudomallei</em> was isolated from soil samples from a single site. These findings suggest endemicity of <em>B. pseudomallei</em> in Puerto Rico despite the rarity of reported cases there.</p><p>Melioidosis is rare in the United States. Between 2008 and 2013, 34 cases were reported; only three did not have documented travel to an area endemic for melioidosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/39\" class=\"abstract_t\">39</a>]. Despite extensive investigation, the source of the infection in these three cases could not be identified [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/40\" class=\"abstract_t\">40</a>].</p><p>Despite better recognition and increased surveillance of infection, the full extent of global distribution of <em>B. pseudomallei</em> remains unclear, especially to what extent melioidosis has spread beyond historical locations and the timing and modes of global spread [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/41\" class=\"abstract_t\">41</a>]. Phylogenetic analysis of autochthonous cases from Madagascar and other isolates from a global dataset suggests spread of <em>B. pseudomallei </em>from Asia to Africa, with subsequent spread from West Africa to the Americas that was potentially linked to the slave trade [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/42\" class=\"abstract_t\">42</a>]. Statistical modelling of clinical cases and environmental studies globally estimated that in 2015 there may have been 165,000 melioidosis cases globally, with 89,000 deaths [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/43\" class=\"abstract_t\">43</a>]. That study predicted that melioidosis was likely to be endemic in 34 countries that so far have had no confirmed cases. Targeted surveillance, together with support for improved regional microbiology facilities, are needed to reveal the accuracy of these predictions [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/44\" class=\"abstract_t\">44</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Transmission</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Transmission of infection can occur via percutaneous inoculation, inhalation, aspiration, and occasionally ingestion. Early literature suggested that inhalation was the primary route of acquisition of <em>B. pseudomallei</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/45,46\" class=\"abstract_t\">45,46</a>], such as inhalation by soldiers of dusts raised by helicopter rotor blades in Vietnam [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/47\" class=\"abstract_t\">47</a>]. However, it is now understood that the predominant mode of transmission is percutaneous inoculation during exposure to wet season soils or contaminated water [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/5,24,48\" class=\"abstract_t\">5,24,48</a>]. Cases of pneumonia following presumptive inoculating skin injuries are well documented, suggesting that the organism can reach the lungs via the hematogenous route [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/24\" class=\"abstract_t\">24</a>].</p><p>During severe weather events such as tropical storms and cyclones, there may be a shift from inoculation to inhalation as the primary mode of <em>B. pseudomallei</em> transmission [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/49-52\" class=\"abstract_t\">49-52</a>]. Rainfall in the two weeks prior to onset of symptoms may be an independent risk factor for a pneumonic presentation, septic shock, and death [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/49\" class=\"abstract_t\">49</a>]. Cases of melioidosis pneumonia that occurred at the time of the December 2004 tsunami in the Indian Ocean were associated largely with aspiration events, though inoculation of the organism in the setting of lacerations also may have occurred [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/50-52\" class=\"abstract_t\">50-52</a>]. </p><p>Person-to-person transmission is extremely unusual, despite the large bacterial load in severely ill patients with septicemic pulmonary melioidosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/4,53\" class=\"abstract_t\">4,53</a>]. Mother-infant transmission during breastfeeding has been described in the setting of <em>B. pseudomallei</em> mastitis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/2,54\" class=\"abstract_t\">2,54</a>]. Laboratory-acquired infections and iatrogenic infections from contaminated hospital or surgical equipment occasionally occur [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/4,55-60\" class=\"abstract_t\">4,55-60</a>]. </p><p>Transmission related to animal exposure is very rare; three possible cases have been described in Australia [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/60,61\" class=\"abstract_t\">60,61</a>]. Ingestion [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/24,62,63\" class=\"abstract_t\">24,62,63</a>] and sexual transmission [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/64,65\" class=\"abstract_t\">64,65</a>] are also postulated as uncommon routes of transmission. However, studies have raised the possibility that ingestion of water contaminated with <em>B. pseudomallei</em> may be a more common infecting event than previously thought, especially in endemic regions with unchlorinated water supplies, and that such transmission could explain the much higher rate of parotid and liver abscesses observed in parts of Southeast Asia compared with northern Australia [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/4,41,66\" class=\"abstract_t\">4,41,66</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Fulminant melioidosis can occur in healthy individuals, though severe disease and fatalities are uncommon in those without defined risk factors [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/25,31,67,68\" class=\"abstract_t\">25,31,67,68</a>]. The most important risk factors for melioidosis are diabetes, hazardous alcohol use, chronic renal disease, and chronic lung disease [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/10,31,48,67-71\" class=\"abstract_t\">10,31,48,67-71</a>]. Patients with diabetes are at increased risk for clinical disease and bacteremia as well as asymptomatic infection. Both chronic renal failure and urolithiasis increase the risk for symptomatic melioidosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/14,21,25,67,70\" class=\"abstract_t\">14,21,25,67,70</a>]. </p><p><em>B. pseudomallei</em> can cause colonization and pulmonary infections in patients with cystic fibrosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/72-75\" class=\"abstract_t\">72-75</a>]. It is recommended that patients with cystic fibrosis traveling to melioidosis endemic areas be warned about the possibility of infection with <em>B. pseudomallei</em> and that it can cause problems analogous to <em>Burkholderia cepacia </em>[<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/76\" class=\"abstract_t\">76</a>]. Other risk factors include chronic lung disease (present in 27 percent of cases in the Northern Territory Study) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/25\" class=\"abstract_t\">25</a>], thalassemia [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/67\" class=\"abstract_t\">67</a>], and kava consumption [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/24\" class=\"abstract_t\">24</a>]. </p><p>Malignancy, steroid and other immunosuppressive therapy, rheumatic heart disease <span class=\"nowrap\">and/or</span> congestive cardiac failure [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31\" class=\"abstract_t\">31</a>], pulmonary hemosiderosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/77\" class=\"abstract_t\">77</a>], chronic granulomatous disease [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/78\" class=\"abstract_t\">78</a>], and tuberculosis are probable risk factors, but are not yet confirmed to be independent risk factors [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/67\" class=\"abstract_t\">67</a>]. </p><p>Children with melioidosis are less likely than adults to have identifiable risk factors [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/79-82\" class=\"abstract_t\">79-82</a>]. One study from Malaysia reported that the risk of melioidosis was substantially higher among children with thalassemia major until universal iron chelation therapy was introduced [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/83\" class=\"abstract_t\">83</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">TIME COURSE OF INFECTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serologic studies suggest that most infections with <em>B. pseudomallei</em> are asymptomatic [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/84\" class=\"abstract_t\">84</a>]; severe clinical disease occurs mainly in those with risk factors [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31,85-89\" class=\"abstract_t\">31,85-89</a>]. </p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Incubation period</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The incubation period following inoculating injury ranges from 1 to 21 days (mean nine days) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/59,90\" class=\"abstract_t\">59,90</a>]. Rapid onset of melioidosis (within 24 hours of inoculation) has been seen in the setting of presumed aspiration following near-drowning [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/91,92\" class=\"abstract_t\">91,92</a>], as well as in a small number of patients with heavy environmental exposure [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/90\" class=\"abstract_t\">90</a>]. The incubation period is likely influenced by the inoculating dose, mode of transmission, host risk factors, and variable virulence properties of the isolate [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/47,93\" class=\"abstract_t\">47,93</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Acute and chronic infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute disease is defined as symptoms lasting for less than two months before diagnosis. Chronic disease is defined as symptoms persisting for longer than two months [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/90\" class=\"abstract_t\">90</a>].</p><p>Most <em>B. pseudomallei</em> infections are probably asymptomatic. When symptoms are present, acute disease is the most common presentation. Of 540 cases of culture-confirmed melioidosis prospectively documented over 20 years in northern Australia (the Darwin Study), 89 percent presented with acute illness and 11 percent presented with chronic illness [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31\" class=\"abstract_t\">31</a>]. Of those with chronic melioidosis, the majority presented with either pneumonia, which commonly mimicked tuberculosis, or with a non-healing skin ulcer or abscess. (See <a href=\"#H10\" class=\"local\">'Pneumonia'</a> below and <a href=\"#H11\" class=\"local\">'Skin ulcers or abscesses'</a> below.)</p><p>The majority of endemic clinical cases of melioidosis occur in the monsoonal wet seasons: 75 percent of cases in northeast Thailand [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/70\" class=\"abstract_t\">70</a>] and 81 percent of cases in the Northern Territory of Australia [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31\" class=\"abstract_t\">31</a>]. The proximity of symptoms to the wet seasons suggests that most infections in endemic areas are acute [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/6,10,24,31,69,87\" class=\"abstract_t\">6,10,24,31,69,87</a>]. </p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Latent infection with reactivation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infection with <em>B. pseudomallei</em> can be latent and subsequently activate, analogous to tuberculosis. The reported latent periods between exposure in an endemic region and the development of melioidosis in a non-endemic region have been as long as 26 to 62 years in the United States [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/94-96\" class=\"abstract_t\">94-96</a>] and 19 to 24 years in Australia [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/97,98\" class=\"abstract_t\">97,98</a>], although reassessment of the report that suggested a 62-year latent period has indicated that ascertainment of the timing of initial infection was incorrect.</p><p>Following the Vietnam War, approximately 225,000 returning military personnel were estimated to be at potential risk of reactivation melioidosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/99\" class=\"abstract_t\">99</a>]. While occasional cases of <em>B. pseudomallei</em> reactivation occur in Vietnam veterans [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/46,94\" class=\"abstract_t\">46,94</a>], documented cases of reactivation were rare relative to the number of individuals exposed. In the Darwin Study (540 cases of cultured-confirmed prospectively followed over 20 years in Northern Australia), only 4 percent of cases of melioidosis were felt to result from reactivation of <em>B. pseudomallei</em> from a latent focus [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31\" class=\"abstract_t\">31</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most <em>B. pseudomallei</em> infections are subclinical. The most common clinical manifestations are pneumonia and localized skin infection. Over half of all patients are bacteremic and up to a quarter can present with septic shock (<a href=\"image.htm?imageKey=ID%2F65943\" class=\"graphic graphic_table graphicRef65943 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31,82\" class=\"abstract_t\">31,82</a>]. Bacteremic spread of the organism can result in clinical manifestations involving virtually any site. </p><p class=\"headingAnchor\" id=\"H100078059\"><span class=\"h2\">Clinical features by age</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common clinical presentations of <em>B. pseudomallei</em> infection vary by age and geographic region. </p><p>Most cases of melioidosis occur in adults. As an example, in a study of melioidosis cases identified and prospectively followed in Northern Australia from 1989 to 2013, only 45 of 820 culture confirmed cases (5 percent) were in individuals younger than 17 years [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/82\" class=\"abstract_t\">82</a>]. In contrast to adults, cutaneous skin infections were common in children (60 versus 13 percent of cases in adults), and children were more likely to have had a specific inoculating event that resulted in disease. Pneumonia and bacteremia occurred infrequently in children (20 and 16 percent), whereas in adults, pneumonia is the most common primary presentation (54 percent).</p><p>Lower or similar mortality rates in children compared with adults have been reported, although mortality in neonates is exceptionally high (75 percent in one systematic review [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/100\" class=\"abstract_t\">100</a>]).</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pneumonia is the most common clinical presentation of melioidosis in all studies [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/2,5,9,10,14,21,47,48,69,101,102\" class=\"abstract_t\">2,5,9,10,14,21,47,48,69,101,102</a>], accounting for half of the Northern Territory cases (<a href=\"image.htm?imageKey=ID%2F50083\" class=\"graphic graphic_diagnosticimage graphicRef50083 \">image 1</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31\" class=\"abstract_t\">31</a>]. An acute presentation may consist of high fever, cough, sputum, chills, rigors, and respiratory distress with or without shock [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/103\" class=\"abstract_t\">103</a>]. A subacute or chronic presentation may consist of cough, purulent sputum production, hemoptysis, and night sweats, suggestive of tuberculosis (<a href=\"image.htm?imageKey=ID%2F52122\" class=\"graphic graphic_diagnosticimage graphicRef52122 \">image 2</a>).</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Skin ulcers or abscesses</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the Darwin Study (540 cases of cultured-confirmed melioidosis prospectively followed over 20 years in Northern Australia), 28 percent of patients without bacteremia presented with skin ulcers or abscesses (<a href=\"image.htm?imageKey=ID%2F50821\" class=\"graphic graphic_picture graphicRef50821 \">picture 1</a> and <a href=\"image.htm?imageKey=ID%2F80092\" class=\"graphic graphic_picture graphicRef80092 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31,104\" class=\"abstract_t\">31,104</a>]. Frequently, these lesions failed to respond to oral antibiotics administered prior to admission. Diffuse cellulitis was rare, however.</p><p class=\"headingAnchor\" id=\"H16109848\"><span class=\"h2\">Bacteremia and sepsis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the Darwin Study (540 cases of cultured-confirmed melioidosis prospectively followed over 20 years in Northern Australia), 55 percent of patients had bacteremia, with 20 percent mortality (<a href=\"image.htm?imageKey=ID%2F66663\" class=\"graphic graphic_diagnosticimage graphicRef66663 \">image 3</a> and <a href=\"image.htm?imageKey=ID%2F69299\" class=\"graphic graphic_picture graphicRef69299 \">picture 3</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31\" class=\"abstract_t\">31</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Genitourinary</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Genitourinary melioidosis presents with fever in association with suprapubic pain, dysuria, difficulty passing urine, or acute urinary retention requiring catheterization [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/105-107\" class=\"abstract_t\">105-107</a>]. Diarrhea frequently accompanies these symptoms. A tender, boggy prostate may be found on rectal examination (<a href=\"image.htm?imageKey=ID%2F55961\" class=\"graphic graphic_diagnosticimage graphicRef55961 \">image 4</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/107\" class=\"abstract_t\">107</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Septic arthritis or osteomyelitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Symptoms and signs of septic arthritis or osteomyelitis may be a presenting complaint (3 percent in the Darwin study) (<a href=\"image.htm?imageKey=ID%2F75905\" class=\"graphic graphic_picture graphicRef75905 \">picture 4</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/9,31,48,108,109\" class=\"abstract_t\">9,31,48,108,109</a>]. In another 4 percent of patients in the Darwin study, septic arthritis or osteomyelitis developed after the initial presentation.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Encephalomyelitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Encephalomyelitis due to melioidosis accounts for approximately 4 percent of melioidosis cases in northern Australia and is rarely reported elsewhere. The clinical presentation usually occurs as a result of encephalomyelitis involving primarily the brainstem; brainstem abscesses can also occur. Prominent features include unilateral upper motor neuron limb weakness, cerebellar signs, cranial nerve palsies (particularly VI, VII nerve palsy and bulbar palsy), or flaccid paraparesis alone (<a href=\"image.htm?imageKey=ID%2F77760\" class=\"graphic graphic_diagnosticimage graphicRef77760 \">image 5</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/110,111\" class=\"abstract_t\">110,111</a>]. Most have a normal or near-normal initial state of consciousness. </p><p>In northern Australian, all described cases of melioidosis encephalomyelitis have had elevated white blood cell counts in the cerebrospinal fluid (CSF). Counts ranged from 30 to 775 cells per microL, predominantly mononuclear cells [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/110,111\" class=\"abstract_t\">110,111</a>]. CSF protein has also been elevated in all cases, with glucose normal or slightly decreased.</p><p>That melioidosis encephalomyelitis appears mostly restricted to cases in Australia may reflect regional genotypic differences between <em>B. pseudomallei </em>strains [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/112\" class=\"abstract_t\">112</a>]. Animal studies suggest that brainstem infection can result from direct nerve root translocation of the bacteria from the nasal passages [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/113\" class=\"abstract_t\">113</a>]. Similar nerve root translocation from skin sources has also been posited [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/82\" class=\"abstract_t\">82</a>]. </p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Other foci of infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Additional foci include parenchymal abscesses and parotitis. Less common foci described in case reports or case series include mycotic aneurysms [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31,114-119\" class=\"abstract_t\">31,114-119</a>], mediastinal masses [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31\" class=\"abstract_t\">31</a>], pericardial collections [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/9,25,120\" class=\"abstract_t\">9,25,120</a>] (<a href=\"image.htm?imageKey=ID%2F62045\" class=\"graphic graphic_diagnosticimage graphicRef62045 \">image 6</a>), and adrenal abscesses [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/25,121-123\" class=\"abstract_t\">25,121-123</a>]. </p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">Abscesses within organs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Abscesses in internal organs are well recognized, especially in the spleen, kidney, prostate (<a href=\"image.htm?imageKey=ID%2F55961\" class=\"graphic graphic_diagnosticimage graphicRef55961 \">image 4</a>) and liver (<a href=\"image.htm?imageKey=ID%2F56531\" class=\"graphic graphic_diagnosticimage graphicRef56531 \">image 7</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/9,25,48\" class=\"abstract_t\">9,25,48</a>]. Fevers, chills, and rigors with and without hypotension are common, but localizing symptoms are often absent. Brain abscesses secondary to bacteremic spread are uncommon, but unlike encephalomyelitis, do not appear to be geographically restricted [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/124\" class=\"abstract_t\">124</a>]. </p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h3\">Parotitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Suppurative parotitis is a common presentation of melioidosis in children in Thailand and Cambodia, accounting for up to 40 percent of cases among Thai children [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/79,80,125\" class=\"abstract_t\">79,80,125</a>]. Children present with parotid pain accompanied by swelling and tenderness. Parotitis is far less common in Australia. Ingestion of water contaminated with <em>B. pseudomallei</em> may at least in part explain the higher rates of parotitis seen in parts of Southeast Asia [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/41,66\" class=\"abstract_t\">41,66</a>].</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Colonization</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with chronic lung disease and infection with <em>B. pseudomallei </em>who are not adequately treated may have residual respiratory colonization following resolution of overt signs of disease. In the majority of such cases, residual colonization is associated with at least low-grade lung infection or disease elsewhere, and there is a significant risk of subsequent invasive disease [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/76,90,126\" class=\"abstract_t\">76,90,126</a>]. Therefore, isolation of <em>B. pseudomallei</em> from any clinical specimen generally warrants treatment. With appropriate treatment, persisting colonization is exceptionally uncommon [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/127\" class=\"abstract_t\">127</a>].</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The likelihood of diagnosing melioidosis is maximized if appropriate clinical samples are obtained from symptomatic at-risk patients from a variety of sites and are sent to the microbiology laboratory for microscopy and culture.</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Laboratory testing</span></p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h3\">Appropriate clinical samples</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>All patients with suspected melioidosis should have the following samples, if available, taken for culture:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Blood</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sputum</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Urine</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Swab of an ulcer or skin lesion</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abscess fluid</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Throat swab</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rectal swab</p><p/><p class=\"headingAnchor\" id=\"H22\"><span class=\"h3\">Culture</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Culture is the mainstay of diagnosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/128\" class=\"abstract_t\">128</a>]. Ashdown's agar, which contains <a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a>, or Ashdown&rsquo;s liquid transport broth, which contains <a href=\"topic.htm?path=colistin-colistimethate-drug-information\" class=\"drug drug_general\">colistin</a>, allows selective growth of <em>B. pseudomallei</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/129\" class=\"abstract_t\">129</a>]. Plating or inoculation of sputum or swabs from the throat, ulcers, skin lesions, and rectum enhance recovery of the organism, particularly if delays in transport of samples are likely. </p><p>Alternative selective culture media have been compared with Ashdown's medium [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/130\" class=\"abstract_t\">130</a>]. <em>B. pseudomallei</em> grow in a wide range of commercially available blood culture media. Commercially available lysis centrifugation blood culture systems, when positive, grow in a shorter time than conventional broth cultures but overall are less sensitive for recovery of the organism [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/131\" class=\"abstract_t\">131</a>].</p><p>Identification of <em>B. pseudomallei</em> can be made by combining the commercial API 20NE or 20E biochemical kit with a simple screening system. This screening system includes Gram stain, the oxidase reaction, typical growth characteristics, and resistance to certain antibiotics [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/132,133\" class=\"abstract_t\">132,133</a>]. However, concerns have been raised about the low sensitivity of some biochemical tests and that the potential for misidentification by some commercial automated biochemical identification systems [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/5,134-138\" class=\"abstract_t\">5,134-138</a>].</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h3\">Microscopy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gram stain of sputum and abscess pus may reveal gram-negative bacilli of <em>B. pseudomallei</em>. The organisms often have a characteristic bipolar staining with a &quot;safety pin&quot; appearance, particularly when the stain is performed from cultured isolates rather than directly from a clinical specimen (<a href=\"image.htm?imageKey=ID%2F78288\" class=\"graphic graphic_picture graphicRef78288 \">picture 5</a>).</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h3\">Serology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serologic testing alone is not a reliable method of diagnosis. Indirect hemagglutination test (IHAT) and other serologic tests are available, but their utility is limited [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/139\" class=\"abstract_t\">139</a>]. False negative serology has been reported in acute sepsis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/140\" class=\"abstract_t\">140</a>], and significant background rates of positive antibody to <em>B. pseudomallei</em> occur in healthy individuals in endemic areas [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/1,89,141\" class=\"abstract_t\">1,89,141</a>].</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h3\">Other techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A variety of other antigen and DNA-detection techniques have been used to increase the diagnostic yield, the rapidity of establishing a diagnosis, or to confirm isolate identity. Most of these techniques are not yet commercially available [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/133,141-147\" class=\"abstract_t\">133,141-147</a>]. Rapid immunofluorescence microscopy of pus, sputum, and urine has been useful in Thailand [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/148\" class=\"abstract_t\">148</a>]. Polymerase chain reaction (PCR) has been tried but until recently has not been sufficiently sensitive or specific for direct detection from clinical samples (eg, blood) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/145,149,150\" class=\"abstract_t\">145,149,150</a>]. However, PCR is being increasingly used for confirmation of bacterial isolates cultured from clinical samples [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/135\" class=\"abstract_t\">135</a>], as is matrix-assisted laser <span class=\"nowrap\">desorption/ionization-time</span> of flight mass spectrometry (MALDI-TOF MS) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/151\" class=\"abstract_t\">151</a>]. With larger database profiles, <em>B. pseudomallei </em>is less frequently incorrectly identified as other <em>Burkholderia </em>species. A lateral flow immunoassay shows promise for the rapid diagnosis of melioidosis directly from clinical samples [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/152\" class=\"abstract_t\">152</a>].</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h2\">Imaging</span></p><p class=\"headingAnchor\" id=\"H27\"><span class=\"h3\">Chest radiography</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chest radiographic findings vary widely in melioidosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/103,153,154\" class=\"abstract_t\">103,153,154</a>]. </p><p>Findings in acute pneumonia due to melioidosis may include discrete, diffuse or patchy lobar or multilobar consolidation, necrotizing lesions, and pleural effusions (<a href=\"image.htm?imageKey=ID%2F50083\" class=\"graphic graphic_diagnosticimage graphicRef50083 \">image 1</a> and <a href=\"image.htm?imageKey=ID%2F66663\" class=\"graphic graphic_diagnosticimage graphicRef66663 \">image 3</a>). The initial chest radiograph may reveal smaller infiltrates than expected in severely ill bacteremic patients. Cavitation and abscesses with fluid levels are frequent.</p><p>Findings in chronic melioidosis may include cavitating, nodular, or streaky infiltrates with fibrotic changes, mimicking tuberculosis (<a href=\"image.htm?imageKey=ID%2F52122\" class=\"graphic graphic_diagnosticimage graphicRef52122 \">image 2</a>). Upper lobe consolidation is especially common in chronic melioidosis, but can also often be seen in acute presentations. Some patients present with pleural effusion alone. Mediastinal lymphadenopathy and abscesses occur with or without pulmonary infiltrates, though melioidosis does not usually cause calcification.</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h3\">Computed tomography and magnetic resonance imaging</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A computed tomographic (CT) scan of the abdomen and pelvis should be performed routinely in all adult patients with confirmed or suspected melioidosis, to evaluate for asymptomatic abscesses in the prostate (<a href=\"image.htm?imageKey=ID%2F55961\" class=\"graphic graphic_diagnosticimage graphicRef55961 \">image 4</a>), spleen (frequently multifocal), liver (<a href=\"image.htm?imageKey=ID%2F56531\" class=\"graphic graphic_diagnosticimage graphicRef56531 \">image 7</a>), and kidneys [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/24,107,153\" class=\"abstract_t\">24,107,153</a>]. In children and adult females who are not systemically ill, an abdominal ultrasound may be used as an alternative to CT scan to avoid radiation exposure.</p><p>Patients with melioidosis encephalomyelitis usually have normal head CT scans; however, magnetic resonance imaging (MRI) usually reveals dramatic changes with extensive increased signal intensity on T2-weighted scans (<a href=\"image.htm?imageKey=ID%2F77760\" class=\"graphic graphic_diagnosticimage graphicRef77760 \">image 5</a>). In the setting of flaccid paraparesis, similar changes may be observed in the spinal cord [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/111\" class=\"abstract_t\">111</a>].</p><p class=\"headingAnchor\" id=\"H16110041\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Melioidosis is an infection caused by the facultative intracellular gram-negative bacterium, <em>Burkholderia pseudomallei</em>. This organism is a widely distributed environmental saprophyte in soil and surface water in endemic regions. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Melioidosis occurs predominantly in Southeast Asia, northern Australia, South Asia, and China. Northeastern Thailand and parts of northern Australia are &quot;hyperendemic&quot; for melioidosis, with seasonal peaks in the wet seasons. Melioidosis outside these regions has been attributed to acquisition by visitors to endemic areas, with symptoms arising following departure from the endemic area. However, sporadic cases have been described outside these regions and modeling studies suggest that melioidosis is likely to be endemic in several countries that thus far have had no confirmed cases, making the endemic boundaries of melioidosis less clear. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The predominant mode of transmission is percutaneous inoculation during exposure to wet season soils or contaminated water. The organism can reach the lung via the hematogenous route or, rarely, via aspiration of contaminated water. During severe weather events with heavy rain, there may be a shift from inoculation to inhalation as the primary mode of <em>B. pseudomallei</em> transmission. Ingestion from unchlorinated water supplies may be more common than previously appreciated. (See <a href=\"#H3\" class=\"local\">'Transmission'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most important risk factors for melioidosis are diabetes, hazardous alcohol use, and chronic renal disease. <em>B. pseudomallei</em> can cause colonization and pulmonary infections in patients with cystic fibrosis. Children may develop infection without having associated risk factors. (See <a href=\"#H4\" class=\"local\">'Risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most <em>B. pseudomallei</em> infections are likely subclinical. However in those with clinical disease (ie, melioidosis), bacteremia occurs in around half of cases and septic shock in up to a quarter. The most common clinical manifestations are pneumonia and localized skin infection. Findings in acute pneumonia due to melioidosis may include discrete, diffuse or patchy lobar or multilobar consolidation, necrotizing lesions, and pleural effusions (<a href=\"image.htm?imageKey=ID%2F50083\" class=\"graphic graphic_diagnosticimage graphicRef50083 \">image 1</a> and <a href=\"image.htm?imageKey=ID%2F66663\" class=\"graphic graphic_diagnosticimage graphicRef66663 \">image 3</a>); findings in chronic melioidosis may include cavitating, nodular, or streaky infiltrates with fibrotic changes, mimicking tuberculosis (<a href=\"image.htm?imageKey=ID%2F52122\" class=\"graphic graphic_diagnosticimage graphicRef52122 \">image 2</a>). Skin infection typically manifests as skin ulcer or abscess and is more commonly seen in children (<a href=\"image.htm?imageKey=ID%2F50821\" class=\"graphic graphic_picture graphicRef50821 \">picture 1</a> and <a href=\"image.htm?imageKey=ID%2F80092\" class=\"graphic graphic_picture graphicRef80092 \">picture 2</a>). (See <a href=\"#H9\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Less commonly, melioidosis can also present with a variety of clinical manifestations involving any organ, generally due to bacteremic spread of the organism (<a href=\"image.htm?imageKey=ID%2F65943\" class=\"graphic graphic_table graphicRef65943 \">table 1</a>). <em>B. pseudomallei</em> also have the potential to reactivate, with a latent period that can last decades. (See <a href=\"#H9\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Culture is the mainstay of diagnosis. Gram stain of sputum and abscess pus may reveal gram-negative bacilli of <em>B. pseudomallei</em>. The organisms often have a characteristic bipolar staining with a &quot;safety pin&quot; appearance. Serologic testing alone is not a reliable method of diagnosis. (See <a href=\"#H19\" class=\"local\">'Diagnosis'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/1\" class=\"nounderline abstract_t\">White NJ. Melioidosis. Lancet 2003; 361:1715.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/2\" class=\"nounderline abstract_t\">Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18:383.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/3\" class=\"nounderline abstract_t\">Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med 2012; 367:1035.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/4\" class=\"nounderline abstract_t\">Dance DA. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop 2000; 74:159.</a></li><li class=\"breakAll\">Dance DB. Melioidosis. Reviews Med Microbiol 1990; 1:143.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/6\" class=\"nounderline abstract_t\">Dance DA. Melioidosis: the tip of the iceberg? Clin Microbiol Rev 1991; 4:52.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/7\" class=\"nounderline abstract_t\">Dance DA. Melioidosis as an emerging global problem. Acta Trop 2000; 74:115.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/8\" class=\"nounderline abstract_t\">Currie BJ, Dance DA, Cheng AC. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg 2008; 102 Suppl 1:S1.</a></li><li class=\"breakAll\">Punyagupta S. Melioidosis. Review of 686 cases and presentation of a new clinical classification. In: Melioidosis, Punyagupta S, Sirisanthana T, Stapatayavong B (Eds), Bangkok Medical Publisher, Bangkok 1989.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/10\" class=\"nounderline abstract_t\">Chaowagul W, White NJ, Dance DA, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989; 159:890.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/11\" class=\"nounderline abstract_t\">Vuddhakul V, Tharavichitkul P, Na-Ngam N, et al. Epidemiology of Burkholderia pseudomallei in Thailand. Am J Trop Med Hyg 1999; 60:458.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/12\" class=\"nounderline abstract_t\">Leelarasamee A. Melioidosis in Southeast Asia. Acta Trop 2000; 74:129.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/13\" class=\"nounderline abstract_t\">Puthucheary SD, Lin HP, Yap PK. Acute septicaemic melioidosis: a report of seven cases. Trop Geogr Med 1981; 33:19.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/14\" class=\"nounderline abstract_t\">Puthucheary SD, Parasakthi N, Lee MK. Septicaemic melioidosis: a review of 50 cases from Malaysia. Trans R Soc Trop Med Hyg 1992; 86:683.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/15\" class=\"nounderline abstract_t\">Vadivelu J, Puthucheary SD, Mifsud A, et al. Ribotyping and DNA macrorestriction analysis of isolates of Burkholderia pseudomallei from cases of melioidosis in Malaysia. Trans R Soc Trop Med Hyg 1997; 91:358.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/16\" class=\"nounderline abstract_t\">Hassan MR, Pani SP, Peng NP, et al. Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia. BMC Infect Dis 2010; 10:302.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/17\" class=\"nounderline abstract_t\">Chan KW, Jayaratnam FJ, Teo SK. Acute septicaemic melioidosis. A report of three fatal cases. Singapore Med J 1985; 26:382.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/18\" class=\"nounderline abstract_t\">Tan AL, Ang BS, Ong YY. Melioidosis: epidemiology and antibiogram of cases in Singapore. Singapore Med J 1990; 31:335.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/19\" class=\"nounderline abstract_t\">Yap EH, Chan YC, Goh KT, et al. Sudden unexplained death syndrome--a new manifestation in melioidosis? Epidemiol Infect 1991; 107:577.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/20\" class=\"nounderline abstract_t\">Yap EH, Thong TW, Tan AL, et al. Comparison of Pseudomonas pseudomallei from humans, animals, soil and water by restriction endonuclease analysis. Singapore Med J 1995; 36:60.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/21\" class=\"nounderline abstract_t\">Singapore Committee on Epidemic Diseases: Melioidosis in Singapore. Epidemiological News Bulletin 1995; 21:69.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/22\" class=\"nounderline abstract_t\">Lim MK, Tan EH, Soh CS, Chang TL. Burkholderia pseudomallei infection in the Singapore Armed Forces from 1987 to 1994--an epidemiological review. Ann Acad Med Singapore 1997; 26:13.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/23\" class=\"nounderline abstract_t\">Lo TJ, Ang LW, James L, Goh KT. Melioidosis in a tropical city state, Singapore. Emerg Infect Dis 2009; 15:1645.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/24\" class=\"nounderline abstract_t\">Currie BJ, Fisher DA, Howard DM, et al. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 2000; 74:121.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/25\" class=\"nounderline abstract_t\">Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 2000; 31:981.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/26\" class=\"nounderline abstract_t\">Malczewski AB, Oman KM, Norton RE, Ketheesan N. Clinical presentation of melioidosis in Queensland, Australia. Trans R Soc Trop Med Hyg 2005; 99:856.</a></li><li class=\"breakAll\">Warner J, Learoyd D, Pelowa D, et al. Melioidosis in the Western Province of Papua New Guinea. In: Annual Scientific Meeting, Medical Society of Papua New Guinea, Port Moresby 1998.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/28\" class=\"nounderline abstract_t\">Le Hello S, Currie BJ, Godoy D, et al. Melioidosis in New Caledonia. Emerg Infect Dis 2005; 11:1607.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/29\" class=\"nounderline abstract_t\">Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, et al. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg 2010; 82:1113.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/30\" class=\"nounderline abstract_t\">Saravu K, Mukhopadhyay C, Vishwanath S, et al. Melioidosis in southern India: epidemiological and clinical profile. Southeast Asian J Trop Med Public Health 2010; 41:401.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/31\" class=\"nounderline abstract_t\">Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 2010; 4:e900.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/32\" class=\"nounderline abstract_t\">Sa&iuml;dani N, Griffiths K, Million M, et al. Melioidosis as a travel-associated infection: Case report and review of the literature. Travel Med Infect Dis 2015; 13:367.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/33\" class=\"nounderline abstract_t\">Dan M. Melioidosis in Travelers: Review of the Literature. Travel Med Infect Dis 2015.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/34\" class=\"nounderline abstract_t\">Miralles IS, Maciel Mdo C, Angelo MR, et al. Burkholderia pseudomallei: a case report of a human infection in Cear&aacute;, Brazil. Rev Inst Med Trop Sao Paulo 2004; 46:51.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/35\" class=\"nounderline abstract_t\">Rolim DB, Vilar DC, Sousa AQ, et al. Melioidosis, northeastern Brazil. Emerg Infect Dis 2005; 11:1458.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/36\" class=\"nounderline abstract_t\">Inglis TJ, Rolim DB, Sousa Ade Q. Melioidosis in the Americas. Am J Trop Med Hyg 2006; 75:947.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/37\" class=\"nounderline abstract_t\">Dance DA. Editorial commentary: melioidosis in Puerto Rico: the iceberg slowly emerges. Clin Infect Dis 2015; 60:251.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/38\" class=\"nounderline abstract_t\">Doker TJ, Sharp TM, Rivera-Garcia B, et al. Contact investigation of melioidosis cases reveals regional endemicity in Puerto Rico. Clin Infect Dis 2015; 60:243.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/39\" class=\"nounderline abstract_t\">Benoit TJ, Blaney DD, Gee JE, et al. Melioidosis Cases and Selected Reports of Occupational Exposures to Burkholderia pseudomallei--United States, 2008-2013. MMWR Surveill Summ 2015; 64:1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/40\" class=\"nounderline abstract_t\">Stewart T, Engelthaler DM, Blaney DD, et al. Epidemiology and investigation of melioidosis, Southern Arizona. Emerg Infect Dis 2011; 17:1286.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/41\" class=\"nounderline abstract_t\">Currie BJ. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. Semin Respir Crit Care Med 2015; 36:111.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/42\" class=\"nounderline abstract_t\">Sarovich DS, Garin B, De Smet B, et al. Phylogenomic Analysis Reveals an Asian Origin for African Burkholderia pseudomallei and Further Supports Melioidosis Endemicity in Africa. mSphere 2016; 1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/43\" class=\"nounderline abstract_t\">Limmathurotsakul D, Golding N, Dance DA, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 2016; 1:15008.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/44\" class=\"nounderline abstract_t\">Currie BJ, Kaestli M. Epidemiology: A global picture of melioidosis. Nature 2016; 529:290.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/45\" class=\"nounderline abstract_t\">Brundage WG, Thuss CJ Jr, Walden DC. Four fatal cases of melioidosis in U. S. soldiers in Vietnam. Bacteriologic and pathologic characteristics. Am J Trop Med Hyg 1968; 17:183.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/46\" class=\"nounderline abstract_t\">Mackowiak PA, Smith JW. Septicemic melioidosis. Occurrence following acute influenza A six years after exposure in Vietnam. JAMA 1978; 240:764.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/47\" class=\"nounderline abstract_t\">Howe C, Sampath A, Spotnitz M. The pseudomallei group: a review. J Infect Dis 1971; 124:598.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/48\" class=\"nounderline abstract_t\">Leelarasamee A, Bovornkitti S. Melioidosis: review and update. Rev Infect Dis 1989; 11:413.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/49\" class=\"nounderline abstract_t\">Currie BJ, Jacups SP. Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis 2003; 9:1538.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/50\" class=\"nounderline abstract_t\">Chierakul W, Winothai W, Wattanawaitunechai C, et al. Melioidosis in 6 tsunami survivors in southern Thailand. Clin Infect Dis 2005; 41:982.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/51\" class=\"nounderline abstract_t\">Allworth AM. Tsunami lung: a necrotising pneumonia in survivors of the Asian tsunami. Med J Aust 2005; 182:364.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/52\" class=\"nounderline abstract_t\">Athan E, Allworth AM, Engler C, et al. Melioidosis in tsunami survivors. Emerg Infect Dis 2005; 11:1638.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/53\" class=\"nounderline abstract_t\">Kunakorn M, Jayanetra P, Tanphaichitra D. Man-to-man transmission of melioidosis. Lancet 1991; 337:1290.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/54\" class=\"nounderline abstract_t\">Ralph A, McBride J, Currie BJ. Transmission of Burkholderia pseudomallei via breast milk in northern Australia. Pediatr Infect Dis J 2004; 23:1169.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/55\" class=\"nounderline abstract_t\">Green RN, Tuffnell PG. Laboratory acquired melioidosis. Am J Med 1968; 44:599.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/56\" class=\"nounderline abstract_t\">Ashdown LR. Nosocomial infection due to Pseudomonas pseudomallei: two cases and an epidemiologic study. Rev Infect Dis 1979; 1:891.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/57\" class=\"nounderline abstract_t\">Schlech WF 3rd, Turchik JB, Westlake RE Jr, et al. Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 1981; 305:1133.</a></li><li class=\"breakAll\">Sookpranee M, Lumbiganon P, Puapermpoonsiri S, et al. Contamination of Savlon solution with Pseudomonas pseudomallei at Srinagarind Hospital. In: Melioidosis, Punyagupta S, Sirisanthana T, Stapatayavong B (Eds), Bangkok Medical Publisher, Bangkok 1989.</li><li class=\"breakAll\">Sookpranee M, Lumbiganon P, Boonma P. Nosocomial contamination of Pseudomonas pseudomallei in the patients at Srinagarind Hospital. In: Melioidosis, Punyagupta S, Sirisanthana T, Stapatayavong B (Eds), Bangkok Medical Publisher, Bangkok 1989.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/60\" class=\"nounderline abstract_t\">Choy JL, Mayo M, Janmaat A, Currie BJ. Animal melioidosis in Australia. Acta Trop 2000; 74:153.</a></li><li class=\"breakAll\">Stanton AT, Fletcher W. Melioidosis, John Bale and Danielson Ltd, London 1932. Vol 21.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/62\" class=\"nounderline abstract_t\">Cottew GS, Sutherland AK, Meehan JF. Melioidosis in sheep in Queensland. Aust Vet J 1952; :113.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/63\" class=\"nounderline abstract_t\">Ketterer PJ, Webster WR, Shield J, et al. Melioidosis in intensive piggeries in south eastern Queensland. Aust Vet J 1986; 63:146.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/64\" class=\"nounderline abstract_t\">Webling DD. Genito-urinary infections with Pseudomonas pseudomallei in Australian Aboriginals. Trans R Soc Trop Med Hyg 1980; 74:138.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/65\" class=\"nounderline abstract_t\">McCormick JB, Sexton DJ, McMurray JG, et al. Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med 1975; 83:512.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/66\" class=\"nounderline abstract_t\">Limmathurotsakul D, Kanoksil M, Wuthiekanun V, et al. Activities of daily living associated with acquisition of melioidosis in northeast Thailand: a matched case-control study. PLoS Negl Trop Dis 2013; 7:e2072.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/67\" class=\"nounderline abstract_t\">Suputtamongkol Y, Chaowagul W, Chetchotisakd P, et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis 1999; 29:408.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/68\" class=\"nounderline abstract_t\">Currie BJ, Jacups SP, Cheng AC, et al. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop Med Int Health 2004; 9:1167.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/69\" class=\"nounderline abstract_t\">Guard RW, Khafagi FA, Brigden MC, Ashdown LR. Melioidosis in Far North Queensland. A clinical and epidemiological review of twenty cases. Am J Trop Med Hyg 1984; 33:467.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/70\" class=\"nounderline abstract_t\">Suputtamongkol Y, Hall AJ, Dance DA, et al. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol 1994; 23:1082.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/71\" class=\"nounderline abstract_t\">Limmathurotsakul D, Chaowagul W, Chierakul W, et al. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis 2006; 43:979.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/72\" class=\"nounderline abstract_t\">Dance DA, Smith MD, Aucken HM, Pitt TL. Imported melioidosis in England and Wales. Lancet 1999; 353:208.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/73\" class=\"nounderline abstract_t\">Visca P, Cazzola G, Petrucca A, Braggion C. Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report. Clin Infect Dis 2001; 32:E15.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/74\" class=\"nounderline abstract_t\">Holland DJ, Wesley A, Drinkovic D, Currie BJ. Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem? Clin Infect Dis 2002; 35:e138.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/75\" class=\"nounderline abstract_t\">O'Carroll MR, Kidd TJ, Coulter C, et al. Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis. Thorax 2003; 58:1087.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/76\" class=\"nounderline abstract_t\">Geake JB, Reid DW, Currie BJ, et al. An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis. BMC Pulm Med 2015; 15:116.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/77\" class=\"nounderline abstract_t\">Ruchin P, Robinson J, Segasothy M, Morey F. Melioidosis in a patient with idiopathic pulmonary haemosiderosis resident in Central Australia. Aust N Z J Med 2000; 30:395.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/78\" class=\"nounderline abstract_t\">Tarlow MJ, Lloyd J. Melioidosis and chronic granulomatous disease. Proc R Soc Med 1971; 64:19.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/79\" class=\"nounderline abstract_t\">Dance DA, Davis TM, Wattanagoon Y, et al. Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis 1989; 159:654.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/80\" class=\"nounderline abstract_t\">Lumbiganon P, Viengnondha S. Clinical manifestations of melioidosis in children. Pediatr Infect Dis J 1995; 14:136.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/81\" class=\"nounderline abstract_t\">Edmond K, Currie B, Brewster D, Kilburn C. Pediatric melioidosis in tropical Australia. Pediatr Infect Dis J 1998; 17:77.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/82\" class=\"nounderline abstract_t\">McLeod C, Morris PS, Bauert PA, et al. Clinical presentation and medical management of melioidosis in children: a 24-year prospective study in the Northern Territory of Australia and review of the literature. Clin Infect Dis 2015; 60:21.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/83\" class=\"nounderline abstract_t\">Fong SM, Wong KJ, Fukushima M, Yeo TW. Thalassemia major is a major risk factor for pediatric melioidosis in Kota Kinabalu, Sabah, Malaysia. Clin Infect Dis 2015; 60:1802.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/84\" class=\"nounderline abstract_t\">Cheng AC, Wuthiekanun V, Limmathurotsakul D, et al. Intensity of exposure and incidence of melioidosis in Thai children. Trans R Soc Trop Med Hyg 2008; 102 Suppl 1:S37.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/85\" class=\"nounderline abstract_t\">NIGG C. SEROLOGIC STUDIES ON SUBCLINICAL MELIOIDOSIS. J Immunol 1963; 91:18.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/86\" class=\"nounderline abstract_t\">Strauss JM, Alexander AD, Rapmund G, et al. Melioidosis in Malaysia. 3. Antibodies to Pseudomonas pseudomallei in the human population. Am J Trop Med Hyg 1969; 18:703.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/87\" class=\"nounderline abstract_t\">Ashdown LR, Guard RW. The prevalence of human melioidosis in Northern Queensland. Am J Trop Med Hyg 1984; 33:474.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/88\" class=\"nounderline abstract_t\">Kanaphun P, Thirawattanasuk N, Suputtamongkol Y, et al. Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in northeast Thailand. J Infect Dis 1993; 167:230.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/89\" class=\"nounderline abstract_t\">Wuthiekanun V, Chierakul W, Langa S, et al. Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand. Am J Trop Med Hyg 2006; 74:1074.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/90\" class=\"nounderline abstract_t\">Currie BJ, Fisher DA, Anstey NM, Jacups SP. Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg 2000; 94:301.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/91\" class=\"nounderline abstract_t\">Achana V, Silpapojakul K, Thininta W, Kalnaowakul S. Acute Pseudomonas pseudomallei pneumonia and septicemia following aspiration of contaminated water: a case report. Southeast Asian J Trop Med Public Health 1985; 16:500.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/92\" class=\"nounderline abstract_t\">Lee N, Wu JL, Lee CH, Tsai WC. Pseudomonas pseudomallei infection from drowning: the first reported case in Taiwan. J Clin Microbiol 1985; 22:352.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/93\" class=\"nounderline abstract_t\">Bovornkitti S, Leelarasamee A, Thamlikitkul V. Melioidosis. Arch Monaldi 1985; 40:203.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/94\" class=\"nounderline abstract_t\">Chodimella U, Hoppes WL, Whalen S, et al. Septicemia and suppuration in a Vietnam veteran. Hosp Pract (1995) 1997; 32:219.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/95\" class=\"nounderline abstract_t\">Mays EE, Ricketts EA. Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure. Chest 1975; 68:261.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/96\" class=\"nounderline abstract_t\">Ngauy V, Lemeshev Y, Sadkowski L, Crawford G. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 2005; 43:970.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/97\" class=\"nounderline abstract_t\">Newland RC. Chronic melioidosis: a case in Sydney. Pathology 1969; 1:149.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/98\" class=\"nounderline abstract_t\">Kingston CW. Chronic or latent melioidosis. Med J Aust 1971; 2:618.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/99\" class=\"nounderline abstract_t\">Clayton AJ, Lisella RS, Martin DG. Melioidosis: a serological survey in military personnel. Mil Med 1973; 138:24.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/100\" class=\"nounderline abstract_t\">Thatrimontrichai A, Maneenil G. Neonatal melioidosis: systematic review of the literature. Pediatr Infect Dis J 2012; 31:1195.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/101\" class=\"nounderline abstract_t\">Currie BJ. Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions. Eur Respir J 2003; 22:542.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/102\" class=\"nounderline abstract_t\">Simpson AJ, Suputtamongkol Y, Smith MD, et al. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 1999; 29:381.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/103\" class=\"nounderline abstract_t\">Meumann EM, Cheng AC, Ward L, Currie BJ. Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis 2012; 54:362.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/104\" class=\"nounderline abstract_t\">Gibney KB, Cheng AC, Currie BJ. Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin Infect Dis 2008; 47:603.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/105\" class=\"nounderline abstract_t\">Kan SK, Kay RW. Melioidosis presenting as prostatitis--a case report from Sabah. Trans R Soc Trop Med Hyg 1978; 72:522.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/106\" class=\"nounderline abstract_t\">Woo ML, Chan PS, French GL. A case of melioidosis presenting with prostatic abscess in Hong Kong. J Urol 1987; 137:120.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/107\" class=\"nounderline abstract_t\">Morse LP, Moller CC, Harvey E, et al. Prostatic abscess due to Burkholderia pseudomallei: 81 cases from a 19-year prospective melioidosis study. J Urol 2009; 182:542.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/108\" class=\"nounderline abstract_t\">Subhadrabandhu T, Prichasuk S, Sathapatayavongs B. Localised melioidotic osteomyelitis. J Bone Joint Surg Br 1995; 77:445.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/109\" class=\"nounderline abstract_t\">Popoff I, Nagamori J, Currie B. Melioidotic osteomyelitis in northern Australia. Aust N Z J Surg 1997; 67:692.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/110\" class=\"nounderline abstract_t\">Woods ML 2nd, Currie BJ, Howard DM, et al. Neurological melioidosis: seven cases from the Northern Territory of Australia. Clin Infect Dis 1992; 15:163.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/111\" class=\"nounderline abstract_t\">Currie BJ, Fisher DA, Howard DM, Burrow JN. Neurological melioidosis. Acta Trop 2000; 74:145.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/112\" class=\"nounderline abstract_t\">Sarovich DS, Price EP, Webb JR, et al. Variable virulence factors in Burkholderia pseudomallei (melioidosis) associated with human disease. PLoS One 2014; 9:e91682.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/113\" class=\"nounderline abstract_t\">St John JA, Walkden H, Nazareth L, et al. Burkholderia pseudomallei Rapidly Infects the Brain Stem and Spinal Cord via the Trigeminal Nerve after Intranasal Inoculation. Infect Immun 2016; 84:2681.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/114\" class=\"nounderline abstract_t\">Steinmetz I, Stosiek P, Hergenr&ouml;ther D, B&auml;r W. Melioidosis causing a mycotic aneurysm. Lancet 1996; 347:1564.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/115\" class=\"nounderline abstract_t\">Lee SS, Liu YC, Wang JH, Wann SR. Mycotic aneurysm due to Burkholderia pseudomallei. Clin Infect Dis 1998; 26:1013.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/116\" class=\"nounderline abstract_t\">Torrens JK, McWhinney PH, Tompkins DS. A deadly thorn: a case of imported melioidosis. Lancet 1999; 353:1016.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/117\" class=\"nounderline abstract_t\">Low JG, Quek AM, Sin YK, Ang BS. Mycotic aneurysm due to Burkholderia pseudomallei infection: case reports and literature review. Clin Infect Dis 2005; 40:193.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/118\" class=\"nounderline abstract_t\">Anunnatsiri S, Chetchotisakd P, Kularbkaew C. Mycotic aneurysm in Northeast Thailand: the importance of Burkholderia pseudomallei as a causative pathogen. Clin Infect Dis 2008; 47:1436.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/119\" class=\"nounderline abstract_t\">Amezyane T, Lecoules S, Algayres JP. Mycotic iliac aneurysm associated with Burkholderia pseudomallei. Int J Infect Dis 2010; 14 Suppl 3:e381.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/120\" class=\"nounderline abstract_t\">Ruff MJ, Lamkin N Jr, Braun J, Barnwell P. Melioidosis complicated by pericarditis. Chest 1976; 69:227.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/121\" class=\"nounderline abstract_t\">Osteraas GR, Hardman JM, Bass JW, Wilson C. Neonatal melioidosis. Am J Dis Child 1971; 122:446.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/122\" class=\"nounderline abstract_t\">Weber DR, Douglass LE, Brundage WG, Stallkamp TC. Acute varieties of melioidosis occurring in U. S. soldiers in Vietnam. Am J Med 1969; 46:234.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/123\" class=\"nounderline abstract_t\">Lee SC, Ling TS, Chen JC, et al. Melioidosis with adrenal gland abscess. Am J Trop Med Hyg 1999; 61:34.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/124\" class=\"nounderline abstract_t\">Chadwick DR, Ang B, Sitoh YY, Lee CC. Cerebral melioidosis in Singapore: a review of five cases. Trans R Soc Trop Med Hyg 2002; 96:72.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/125\" class=\"nounderline abstract_t\">Pagnarith Y, Kumar V, Thaipadungpanit J, et al. Emergence of pediatric melioidosis in Siem Reap, Cambodia. Am J Trop Med Hyg 2010; 82:1106.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/126\" class=\"nounderline abstract_t\">Jenney AW, Lum G, Fisher DA, Currie BJ. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents 2001; 17:109.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/127\" class=\"nounderline abstract_t\">Price EP, Sarovich DS, Mayo M, et al. Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. MBio 2013; 4.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/128\" class=\"nounderline abstract_t\">Hoffmaster AR, AuCoin D, Baccam P, et al. Melioidosis diagnostic workshop, 2013. Emerg Infect Dis 2015; 21.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/129\" class=\"nounderline abstract_t\">Ashdown LR. An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 1979; 11:293.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/130\" class=\"nounderline abstract_t\">Peacock SJ, Chieng G, Cheng AC, et al. Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol 2005; 43:5359.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/131\" class=\"nounderline abstract_t\">Simpson AJ, Howe PA, Wuthiekanun V, White NJ. A comparison of lysis centrifugation, pour plate, and conventional blood culture methods in the diagnosis of septicaemic melioidosis. J Clin Pathol 1999; 52:616.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/132\" class=\"nounderline abstract_t\">Dance DA, Wuthiekanun V, Naigowit P, White NJ. Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE. J Clin Pathol 1989; 42:645.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/133\" class=\"nounderline abstract_t\">Steinmetz I, Reganzerowski A, Brenneke B, et al. Rapid identification of Burkholderia pseudomallei by latex agglutination based on an exopolysaccharide-specific monoclonal antibody. J Clin Microbiol 1999; 37:225.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/134\" class=\"nounderline abstract_t\">Glass MB, Popovic T. Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei. J Clin Microbiol 2005; 43:479.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/135\" class=\"nounderline abstract_t\">Inglis TJ, Merritt A, Chidlow G, et al. Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J Clin Microbiol 2005; 43:2201.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/136\" class=\"nounderline abstract_t\">Lowe P, Engler C, Norton R. Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J Clin Microbiol 2002; 40:4625.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/137\" class=\"nounderline abstract_t\">Amornchai P, Chierakul W, Wuthiekanun V, et al. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J Clin Microbiol 2007; 45:3774.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/138\" class=\"nounderline abstract_t\">Podin Y, Kaestli M, McMahon N, et al. Reliability of automated biochemical identification of Burkholderia pseudomallei is regionally dependent. J Clin Microbiol 2013; 51:3076.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/139\" class=\"nounderline abstract_t\">Cheng AC, O'brien M, Freeman K, et al. Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg 2006; 74:330.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/140\" class=\"nounderline abstract_t\">Appassakij H, Silpapojakul KR, Wansit R, Pornpatkul M. Diagnostic value of the indirect hemagglutination test for melioidosis in an endemic area. Am J Trop Med Hyg 1990; 42:248.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/141\" class=\"nounderline abstract_t\">Sirisinha S, Anuntagool N, Dharakul T, et al. Recent developments in laboratory diagnosis of melioidosis. Acta Trop 2000; 74:235.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/142\" class=\"nounderline abstract_t\">Zysk G, Splettst&ouml;sser WD, Neubauer H. A review on melioidosis with special respect on molecular and immunological diagnostic techniques. Clin Lab 2000; 46:119.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/143\" class=\"nounderline abstract_t\">Anuntagool N, Naigowit P, Petkanchanapong V, et al. Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J Med Microbiol 2000; 49:1075.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/144\" class=\"nounderline abstract_t\">Samosornsuk N, Lulitanond A, Saenla N, et al. Short report: evaluation of a monoclonal antibody-based latex agglutination test for rapid diagnosis of septicemic melioidosis. Am J Trop Med Hyg 1999; 61:735.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/145\" class=\"nounderline abstract_t\">Haase A, Brennan M, Barrett S, et al. Evaluation of PCR for diagnosis of melioidosis. J Clin Microbiol 1998; 36:1039.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/146\" class=\"nounderline abstract_t\">Anuntagool A, Intachote P, Naigowit P, Sirisinha S. Rapid antigen detection assay for identification of Burkholderia (Pseudomonas) pseudomallei infection. J Clin Microbiol 1996; 34:975.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/147\" class=\"nounderline abstract_t\">Smith MD, Wuthiekanun V, Walsh AL, et al. Latex agglutination for rapid detection of Pseudomonas pseudomallei antigen in urine of patients with melioidosis. J Clin Pathol 1995; 48:174.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/148\" class=\"nounderline abstract_t\">Wuthiekanun V, Desakorn V, Wongsuvan G, et al. Rapid immunofluorescence microscopy for diagnosis of melioidosis. Clin Diagn Lab Immunol 2005; 12:555.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/149\" class=\"nounderline abstract_t\">Meumann EM, Novak RT, Gal D, et al. Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J Clin Microbiol 2006; 44:3028.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/150\" class=\"nounderline abstract_t\">Chantratita N, Meumann E, Thanwisai A, et al. Loop-mediated isothermal amplification method targeting the TTS1 gene cluster for detection of Burkholderia pseudomallei and diagnosis of melioidosis. J Clin Microbiol 2008; 46:568.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/151\" class=\"nounderline abstract_t\">Cunningham SA, Patel R. Importance of using Bruker's security-relevant library for Biotyper identification of Burkholderia pseudomallei, Brucella species, and Francisella tularensis. J Clin Microbiol 2013; 51:1639.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/152\" class=\"nounderline abstract_t\">Houghton RL, Reed DE, Hubbard MA, et al. Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis. PLoS Negl Trop Dis 2014; 8:e2727.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/153\" class=\"nounderline abstract_t\">Tan AP, Pui MH, Tan LK. Imaging patterns in melioidosis. Australas Radiol 1995; 39:260.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-melioidosis/abstract/154\" class=\"nounderline abstract_t\">Chong VF, Fan YF. The radiology of melioidosis. Australas Radiol 1996; 40:244.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3146 Version 16.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H16110041\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a><ul><li><a href=\"#H100078067\" id=\"outline-link-H100078067\">Geographic distribution</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">Transmission</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Risk factors</a></li></ul></li><li><a href=\"#H5\" id=\"outline-link-H5\">TIME COURSE OF INFECTION</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">Incubation period</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Acute and chronic infection</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Latent infection with reactivation</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H100078059\" id=\"outline-link-H100078059\">Clinical features by age</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Pneumonia</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Skin ulcers or abscesses</a></li><li><a href=\"#H16109848\" id=\"outline-link-H16109848\">Bacteremia and sepsis</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Genitourinary</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Septic arthritis or osteomyelitis</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Encephalomyelitis</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">Other foci of infection</a><ul><li><a href=\"#H16\" id=\"outline-link-H16\">- Abscesses within organs</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">- Parotitis</a></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">Colonization</a></li></ul></li><li><a href=\"#H19\" id=\"outline-link-H19\">DIAGNOSIS</a><ul><li><a href=\"#H20\" id=\"outline-link-H20\">Laboratory testing</a><ul><li><a href=\"#H21\" id=\"outline-link-H21\">- Appropriate clinical samples</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">- Culture</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">- Microscopy</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">- Serology</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">- Other techniques</a></li></ul></li><li><a href=\"#H26\" id=\"outline-link-H26\">Imaging</a><ul><li><a href=\"#H27\" id=\"outline-link-H27\">- Chest radiography</a></li><li><a href=\"#H28\" id=\"outline-link-H28\">- Computed tomography and magnetic resonance imaging</a></li></ul></li></ul></li><li><a href=\"#H16110041\" id=\"outline-link-H16110041\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/3146|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=ID/50083\" class=\"graphic graphic_diagnosticimage\">- Melioidosis acute pneumonia</a></li><li><a href=\"image.htm?imageKey=ID/52122\" class=\"graphic graphic_diagnosticimage\">- Chronic lung melioidosis</a></li><li><a href=\"image.htm?imageKey=ID/66663\" class=\"graphic graphic_diagnosticimage\">- Melioidosis septicemia</a></li><li><a href=\"image.htm?imageKey=ID/55961\" class=\"graphic graphic_diagnosticimage\">- Melioidosis prostatic abscess</a></li><li><a href=\"image.htm?imageKey=ID/77760\" class=\"graphic graphic_diagnosticimage\">- Melioidosis encephalitis</a></li><li><a href=\"image.htm?imageKey=ID/62045\" class=\"graphic graphic_diagnosticimage\">- Pericardial melioidosis</a></li><li><a href=\"image.htm?imageKey=ID/56531\" class=\"graphic graphic_diagnosticimage\">- Melioidosis liver abscess</a></li></ul></li><li><div id=\"ID/3146|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/73325\" class=\"graphic graphic_figure\">- Global distribution of B pseudomallei and melioidosis</a></li></ul></li><li><div id=\"ID/3146|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/50821\" class=\"graphic graphic_picture\">- Cutaneous melioidosis</a></li><li><a href=\"image.htm?imageKey=ID/80092\" class=\"graphic graphic_picture\">- Melioidosis ulcer</a></li><li><a href=\"image.htm?imageKey=ID/69299\" class=\"graphic graphic_picture\">- Melioidosis lung pathology</a></li><li><a href=\"image.htm?imageKey=ID/75905\" class=\"graphic graphic_picture\">- Melioidosis osteomyelitis</a></li><li><a href=\"image.htm?imageKey=ID/78288\" class=\"graphic graphic_picture\">- Burkholderia pseudomallei Gram stain</a></li></ul></li><li><div id=\"ID/3146|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/65943\" class=\"graphic graphic_table\">- Melioidosis clinical features</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prognosis-of-melioidosis\" class=\"medical medical_review\">Treatment and prognosis of melioidosis</a></li></ul></div></div>","javascript":null}